COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING TEMS
US Application 61/496,737
Filed on 2011-06-14
Filed on 2011-06-14
Mesothelin Domain-Specific Monoclonal Antibodies And Use Thereof
US Application 61/691,719
Filed on 2012-08-21
Filed on 2012-08-21
Auto-recognizing Therapeutic R/DNA Chimeric Nanoparticles (NP)
US Application 61/698,113
Filed on 2012-09-07
Filed on 2012-09-07
THERAPEUTIC RNA SWITCHES COMPOSITIONS AND METHODS OF USE
US Application 61/678,434
Filed on 2012-08-01
Filed on 2012-08-01
Nitric Oxide-Releasing Diazeniumdiolated Polyvinylpyrrolidone-Based Polymers, And Compositions, Medical Devices, And Uses Thereof
US Application 61/672,486
Filed on 2012-07-17
Filed on 2012-07-17
Programmed Death Ligand-1 (PDL1)-transduced K562 Cells Convert Human Th1 Cells Into Regulatory T Cells
US Application 61/564,174
Filed on 2011-11-23
Filed on 2011-11-23
Methods For Generation Of Pluripotent and Multipotent Cells
US Application 61/735,701
Filed on 2012-12-11
Filed on 2012-12-11
TumIor-Specific GM-CSF Cytokine Response as Predictor of Cancer Vaccine Effectiveness
US Application 61/569,131
Filed on 2011-12-09
Filed on 2011-12-09
USE OF PDL1 EXPRESSING CELLS TO CONVERT T CELLS INTO REGULATORY T CELLS
US Application 61/563,273
Filed on 2011-11-23
Filed on 2011-11-23
High-affinity Monoclonal Antibodies To Glypican-3 And Use Thereof
US Application 61/654,232
Filed on 2012-06-01
Filed on 2012-06-01